Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study

Abstract Background Female sex and younger age are reported risk factors for chemotherapy‐induced nausea and vomiting (CINV) in highly emetogenic chemotherapy, but the underlying mechanism has not been elucidated. The purpose of this study was to clarify the impact of menopause on CINV. Methods This...

Full description

Bibliographic Details
Main Authors: Takashi Yokokawa, Kenichi Suzuki, Daiki Tsuji, Mari Hosonaga, Kazuo Kobayashi, Kazuyoshi Kawakami, Hitoshi Kawazoe, Tomonori Nakamura, Wataru Suzuki, Takahito Sugisaki, Takeshi Aoyama, Koki Hashimoto, Masahiro Hatori, Takuya Tomomatsu, Ayaka Inoue, Keiichi Azuma, Maimi Asano, Toshimi Takano, Shinji Ohno, Masakazu Yamaguchi
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
breast cancer
chemotherapy‐induced nausea and vomiting
estradiol
follicle‐stimulating hormone
menopause
risk factor
Online Access:https://doi.org/10.1002/cam4.6494

Internet

https://doi.org/10.1002/cam4.6494

Similar Items